- Home
- CDT vs OP Comparison
CDT vs OP Comparison
Compare CDT & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- OP
- Stock Information
- Founded
- CDT 2019
- OP 2021
- Country
- CDT United States
- OP Greece
- Employees
- CDT 7
- OP N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- OP
- Sector
- CDT Health Care
- OP
- Exchange
- CDT Nasdaq
- OP Nasdaq
- Market Cap
- CDT 9.0M
- OP 10.5M
- IPO Year
- CDT N/A
- OP N/A
- Fundamental
- Price
- CDT $0.07
- OP $1.09
- Analyst Decision
- CDT
- OP
- Analyst Count
- CDT 0
- OP 0
- Target Price
- CDT N/A
- OP N/A
- AVG Volume (30 Days)
- CDT 16.2M
- OP 22.4K
- Earning Date
- CDT 02-14-2025
- OP 12-20-2024
- Dividend Yield
- CDT N/A
- OP N/A
- EPS Growth
- CDT N/A
- OP N/A
- EPS
- CDT N/A
- OP N/A
- Revenue
- CDT N/A
- OP $22,098,000.00
- Revenue This Year
- CDT N/A
- OP N/A
- Revenue Next Year
- CDT N/A
- OP N/A
- P/E Ratio
- CDT N/A
- OP N/A
- Revenue Growth
- CDT N/A
- OP 9.82
- 52 Week Low
- CDT $0.06
- OP $1.04
- 52 Week High
- CDT $5.44
- OP $3.15
- Technical
- Relative Strength Index (RSI)
- CDT 40.15
- OP 17.26
- Support Level
- CDT $0.08
- OP $1.04
- Resistance Level
- CDT $0.09
- OP $1.50
- Average True Range (ATR)
- CDT 0.01
- OP 0.06
- MACD
- CDT -0.00
- OP -0.03
- Stochastic Oscillator
- CDT 27.18
- OP 11.63
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.